Has William Tettelbach, MD received payments from drug or device companies?

Yes. Drug and device makers reported $82,189 in general payments to William Tettelbach, MD across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Tettelbach, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Tettelbach, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Tettelbach, MD

Infectious Disease · Salt Lake City, UTNPI 1336143361

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $75,000 of the $82,189 with a category attached, or 91.3%. Biowound Solutions, Inc. accounts for 89.6% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $70,194, more than ten times the $4,250 reported in 2019. Among infectious disease clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,189in general payments, 2019–2025

Across 54 payments — averaging $1522.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biowound Solutions, Inc.$74K
KCI USA, Inc.$4K
Organogenesis Inc.$1K
Mimedx Group, Inc.$931
Bone Support Inc.$750
Kerecis Limited$516
plus $839 from 6 others

What the payments were for

Consulting fees$75,00091%
Travel & lodging$3,6524%
Food & beverage$3,5374%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biowound Solutions, Inc.	15	$73,652
KCI USA, Inc.	2	$4,272
Organogenesis Inc.	10	$1,228
Mimedx Group, Inc.	12	$931
Bone Support Inc.	2	$750
Kerecis Limited	2	$516
Smith+Nephew	4	$394
Integra Lifesciences Corporation	2	$144
Surgenex LLC	1	$144
Reprise Biomedical, Inc.	1	$72
Acera Surgical, Inc.	1	$46
Solventum Corporation	2	$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

bio-ConneKt$73,652
SNAP$4,250
Kerecis Omega3 Marigen$1,372
Kerecis Omega3 SurgiClose$978
CERAMENTBONE VOID FILLER$750
Affinity$345
INTEGRA$304
PURAPLY WOUND MATRIX$279
Apligraf$275
Stravix$243
Kerecis Omega3 GraftGuide$231
SurGraft$144
SurMatrix$144
ArdeoGraft$144
PelloGraft$144
RenoGraft$144
Grafix$103
Oasis$103
INTEGRA DERMAL REGENERATION TEMPLATE$101
PRIMATRIX$101

How this compares

$82,189 in reported general payments places this provider in the 95th percentile of 44 infectious disease providers in Utah.

See all infectious disease providers in Utah →

Medicare billing

Part B allowed, 2024

$2,371

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Salt Lake City

Kimberly HansonSalt Lake City$22K
Bert LopansriSalt Lake City$20K
David ClassenSalt Lake City$14K
Andrew SkinnerSalt Lake City$10K
Adam SpivakSalt Lake City$5K
Marquam OliverSalt Lake City$4K
Joel TrachtenbergSalt Lake City$2K
Emily Sydnor SpivakSalt Lake City$1K
Sankar SwaminathanSalt Lake City$800
Patricia Ruggeri-WeigelSalt Lake City$737

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →